IS6425A - Nýir sertralínhýdróklóríð fjölgervingar, aðferðirtil að búa þá til, blöndur sem innihalda þá og aðferðir til að nota þá - Google Patents

Nýir sertralínhýdróklóríð fjölgervingar, aðferðirtil að búa þá til, blöndur sem innihalda þá og aðferðir til að nota þá

Info

Publication number
IS6425A
IS6425A IS6425A IS6425A IS6425A IS 6425 A IS6425 A IS 6425A IS 6425 A IS6425 A IS 6425A IS 6425 A IS6425 A IS 6425A IS 6425 A IS6425 A IS 6425A
Authority
IS
Iceland
Prior art keywords
methods
sertraline hydrochloride
polyphenols
making
new
Prior art date
Application number
IS6425A
Other languages
English (en)
Icelandic (is)
Inventor
Aronhime Judith
Mendelovici Marioana
Nidam Tamar
Singer Claude
Original Assignee
Teva Pharmaceutical Industries Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharmaceutical Industries Ltd. filed Critical Teva Pharmaceutical Industries Ltd.
Publication of IS6425A publication Critical patent/IS6425A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/41Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
    • C07C211/42Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS6425A 1999-12-21 2002-06-18 Nýir sertralínhýdróklóríð fjölgervingar, aðferðirtil að búa þá til, blöndur sem innihalda þá og aðferðir til að nota þá IS6425A (is)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17134199P 1999-12-21 1999-12-21
US18733600P 2000-03-06 2000-03-06
US18791000P 2000-03-08 2000-03-08
US19060300P 2000-03-20 2000-03-20
PCT/US2000/035178 WO2001045692A1 (en) 1999-12-21 2000-12-21 Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them

Publications (1)

Publication Number Publication Date
IS6425A true IS6425A (is) 2002-06-18

Family

ID=27496950

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6425A IS6425A (is) 1999-12-21 2002-06-18 Nýir sertralínhýdróklóríð fjölgervingar, aðferðirtil að búa þá til, blöndur sem innihalda þá og aðferðir til að nota þá

Country Status (19)

Country Link
US (2) US6452054B2 (US06858652-20050222-C00002.png)
EP (2) EP1248605B1 (US06858652-20050222-C00002.png)
JP (2) JP4057295B2 (US06858652-20050222-C00002.png)
KR (1) KR100791872B1 (US06858652-20050222-C00002.png)
CN (1) CN1434708A (US06858652-20050222-C00002.png)
AT (1) ATE354358T1 (US06858652-20050222-C00002.png)
AU (1) AU780771B2 (US06858652-20050222-C00002.png)
DE (1) DE60033566T2 (US06858652-20050222-C00002.png)
DK (1) DK1248605T3 (US06858652-20050222-C00002.png)
ES (1) ES2281374T3 (US06858652-20050222-C00002.png)
HR (1) HRP20020543A2 (US06858652-20050222-C00002.png)
HU (1) HUP0204010A3 (US06858652-20050222-C00002.png)
IL (1) IL150332A0 (US06858652-20050222-C00002.png)
IS (1) IS6425A (US06858652-20050222-C00002.png)
PL (1) PL356452A1 (US06858652-20050222-C00002.png)
PT (1) PT1248605E (US06858652-20050222-C00002.png)
SK (1) SK8872002A3 (US06858652-20050222-C00002.png)
WO (1) WO2001045692A1 (US06858652-20050222-C00002.png)
YU (1) YU47902A (US06858652-20050222-C00002.png)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5845313A (en) 1995-07-31 1998-12-01 Lexar Direct logical block addressing flash memory mass storage architecture
US6978342B1 (en) 1995-07-31 2005-12-20 Lexar Media, Inc. Moving sectors within a block of information in a flash memory mass storage architecture
US6500987B1 (en) * 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) * 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
SK8872002A3 (en) 1999-12-21 2002-12-03 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
US6552227B2 (en) * 2000-03-14 2003-04-22 Teva Pharmaceutical Industries Ltd. Process for preparing (+)-cis-sertraline
WO2002096860A1 (en) * 2001-05-31 2002-12-05 Orion Corporation Fermion Process for preparing sertraline intermediates
WO2002096859A1 (en) 2001-05-31 2002-12-05 Orion Corporation Fermion Process for preparing sertraline hydrochloride polymorphic form ii
GB0123421D0 (en) 2001-09-28 2001-11-21 Memquest Ltd Power management system
US6897340B2 (en) 2002-04-29 2005-05-24 Teva Pharmaceutical Industries Ltd. Processes for preparation of polymorphic form II of sertraline hydrochloride
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP2007502329A (ja) 2003-05-23 2007-02-08 トランスフォーム・ファーマシューティカルズ・インコーポレイテッド セルトラリン組成物
CA2537804A1 (en) * 2003-09-05 2005-03-17 Teva Pharmaceutical Industries Ltd A recycling process for preparing sertraline
ZA200603502B (en) * 2003-11-04 2008-02-27 Cipla Ltd Process for the preparation of polymorphs of selective serotonin reuptake inhibitor
US7464306B1 (en) 2004-08-27 2008-12-09 Lexar Media, Inc. Status of overall health of nonvolatile memory
US7345201B2 (en) * 2005-02-23 2008-03-18 Teva Pharmaceutical Industries, Ltd. Processes for preparing sertraline
WO2006103506A1 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Sertraline-containing pharmaceutical compositions and a process for preparation thereof
GB0507090D0 (en) * 2005-04-07 2005-05-11 Sandoz Ag Process for preparing polymorphic form ll of sertraline hydrochloride
US7518019B2 (en) * 2006-06-01 2009-04-14 Hetero Drugs Limited Processes for preparing sertraline hydrochloride crystalline forms
US20060257475A1 (en) * 2006-08-17 2006-11-16 Boehringer Ingelheim International Gmbh Stable Sertraline Hydrochloride Formulation and Method
CA2594198A1 (en) * 2007-07-20 2009-01-20 Apotex Pharmachem Inc. A novel process for the preparation of sertraline hydrochloride form ii
FR2928148B1 (fr) * 2008-02-28 2013-01-18 Sanofi Aventis Procede de preparation de combretastatine
KR102495018B1 (ko) 2013-11-15 2023-02-06 아케비아 테라퓨틱스 인코포레이티드 {[5-(3-클로로페닐)-3-하이드록시피리딘-2-카보닐]아미노}아세트산의 고체형, 이의 조성물 및 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4536518A (en) 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) 1991-03-06 1992-01-21 Pfizer Inc. Process for recycling amine isomer
GB9114947D0 (en) 1991-07-11 1991-08-28 Pfizer Ltd Process for preparing sertraline
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5734083A (en) 1996-05-17 1998-03-31 Torcan Chemical Ltd. Sertraline polymorph
JP2002506844A (ja) 1998-03-18 2002-03-05 チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド シクロヘキシリデンアミンのcis−選択的接触水素化方法
JP2000026379A (ja) * 1998-07-08 2000-01-25 Sumika Fine Chemicals Co Ltd 塩酸セルトラリンメタノール和物および塩酸セルトラリンエタノール和物、ならびにそれらの製法
EP1133459B1 (en) * 1998-11-27 2006-01-11 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride form v
US6500987B1 (en) 1998-11-27 2002-12-31 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride polymorphs
US6495721B1 (en) 1999-08-09 2002-12-17 Teva Pharmaceutical Industries Ltd. Sertraline hydrochloride Form II and methods for the preparation thereof
TWI260315B (en) * 1999-10-29 2006-08-21 Ciba Sc Holding Ag Polymorphic forms of sertraline hydrochloride
SK8872002A3 (en) * 1999-12-21 2002-12-03 Teva Pharma Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and methods of using them
IN192343B (US06858652-20050222-C00002.png) 2000-05-26 2004-04-10 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
DE60033566D1 (de) 2007-04-05
EP1248605B1 (en) 2007-02-21
US20030023117A1 (en) 2003-01-30
EP1797875A3 (en) 2007-08-29
HRP20020543A2 (en) 2005-04-30
KR20020062356A (ko) 2002-07-25
US6858652B2 (en) 2005-02-22
AU780771B2 (en) 2005-04-14
IL150332A0 (en) 2002-12-01
EP1248605A2 (en) 2002-10-16
HUP0204010A2 (hu) 2003-04-28
ES2281374T3 (es) 2007-10-01
WO2001045692A9 (en) 2002-07-04
PT1248605E (pt) 2007-03-30
JP4057295B2 (ja) 2008-03-05
DE60033566T2 (de) 2007-10-25
US20010041815A1 (en) 2001-11-15
US6452054B2 (en) 2002-09-17
WO2001045692A1 (en) 2001-06-28
DK1248605T3 (da) 2007-03-19
JP2007308505A (ja) 2007-11-29
CN1434708A (zh) 2003-08-06
JP2003518056A (ja) 2003-06-03
EP1248605A4 (en) 2004-11-24
SK8872002A3 (en) 2002-12-03
KR100791872B1 (ko) 2008-01-07
EP1797875A2 (en) 2007-06-20
AU2737601A (en) 2001-07-03
HUP0204010A3 (en) 2006-02-28
ATE354358T1 (de) 2007-03-15
PL356452A1 (en) 2004-06-28
YU47902A (sh) 2005-11-28

Similar Documents

Publication Publication Date Title
IS6425A (is) Nýir sertralínhýdróklóríð fjölgervingar, aðferðirtil að búa þá til, blöndur sem innihalda þá og aðferðir til að nota þá
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
NO20030845D0 (no) Utvalgte fusjonerte pyrrolokarbazoler
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
BR0113286A (pt) Pirazóis substituìdos
BR0313265A (pt) Compostos e respectivos processos de preparação, uso e formulações farmacêuticas e métodos de prevenção e/ou tratamento de distúrbios mediados por receptor mglur5 e de inbição da ativação de receptores mglu r5.
ATE551340T1 (de) Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten
PA8493701A1 (es) Compuestos para tratar la obesidad
ATE334662T1 (de) Herstellungsverfahren von arzneizubereitungen
ECSP055584A (es) Proceso para la preparación de fibrinógeno
ATE329588T1 (de) Verwendung von sibutramin zur behandlung von von organischen störungen verursachten zns- erkrankungen
DE60231107D1 (de) Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems
PT1414816E (pt) Polimorfo estavel da flibanserina, processo tecnico para a sua preparacao e sua utilizacao na preparacao de medicamentos
DE60139466D1 (de) Behandlung von diabetes
ATE355067T1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
BR9807936A (pt) Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação
HUP0204318A2 (en) Torsemide polymorphic forms, process for their preparation, pharmaceutical compositions containing them and their use
BR0200249A (pt) Misturas de borracha contendo terpolìmeros
NO20023150D0 (no) Fremgangsmåte for fremstilling av citalopram
NO20031413D0 (no) Ny fremgangsmåte for fremstilling av oksabispidiner
DK0996435T3 (da) Aminosyrederivater anvendelige til behandling af slagtilfælde
BR0016942A (pt) Derivados substituìdos de aminometil-fenil-ciclohexano
CY1107769T1 (el) Συνθετικη διεργασια για ενα ενδιαμεσο προϊον για τις ενωσεις εκτεϊνασκιδινης και φθαλασκιδινης
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
DK1373232T3 (da) Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner